Investing Profile

Anja Konig

VCInvestor
Managing Director Novartis Venture Fund at Novartis
nvfund.comBasel, Switzerland
Photo of Anja Konig, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Mckinsey & Company Network
309 CONNECTIONS
Cornell University Network
256 CONNECTIONS
Novartis Network
53 CONNECTIONS
Novartis Network
53 CONNECTIONS
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
16
$750M
CompanyStageDateRound SizeTotal Raised
Forendo Pharma
Series UnknownJul 2019$6M
Series UnknownSep 2018$5M
Series AOct 2014$15M
$26M
Co-investors: Hakan Goker (MDC Ventures (formerly KBS Ventures))
Bicycle Therapeutics
Series BJun 2017$52M
Series AOct 2014$32M
Series UnknownDec 2012$6M
SeedOct 2009
$90M
Co-investors: Dr. Regina Hodits (Wellington Partners), Deborah Harland (SR One), Bruce Booth (Atlas Venture)
F2G
Private EquityJun 2016$60M
Series UnknownSep 2012$30M
$160M
Co-investors: Nanna Luneborg (Forbion), Joseph Anderson (Sofinnova Partners), Raj Parekh (Advent Life Sciences), Maha Katabi (Sofinnova Investments)
Nabriva Therapeutics
Series BApr 2015$120M
$120M
Covagen
Series BDec 2013$66M
Series ANov 2010$6M
SeedOct 2009
$72M
Co-investors: Abraham Kometz (Deerfield Management)
Oxagen
Series CNov 2009$27M
$27M
PharmAbcine
Series ASep 2009$6M
$6M
Diagnoplex
Series ADec 2008$8M
$9M
Co-investors: Thomas Goebel (Omega Funds)
Managing Director Novartis Venture Fund NovartisPresent
Board Director Covagen AGPresent
Board Director Nabriva Therapeutics plcPresent
Board Director HeptaresPresent
Board Director Bicycle TherapeuticsPresent
Board Director Nxera PharmaPresent
Board director F2GPresent
Board Director Forendo Pharma LtdPresent
Jury member BaseLaunchPresent
Board Director of UZH Life Sciences Fund University of ZurichPresent
Board Director of UZH Life Sciences Fund Univeristy of ZurichPresent
Board director CUTISS AGPresent
Global Head Novartis Venture Fund NovartisPresent
Steering Committee Member and POC Jury BRIDGE Funding ProgrammePresent
Board Director ANAVEON AGPresent
Steering Committee Member BRIDGE Programm (SNSF-Innosuisse)Present
Board Director Ribon TherapeuticsPresent
Investment Committee Member The Chen GroupPresent
Board Director HotmailPresent
Member of the Board of Trustees (Stiftungsrat and Stiftungsratsausschuss) Swiss National Science Foundation SNSFPresent
Independent Board Director (Verwaltungsrat) SensirionPresent
Board Director Mediar TherapeuticsPresent
Director Board of Directors InnosuissePresent
Associate Partner Mckinsey & CompanyPresent
Strategic Assistant to Chairman and CEO NovartisPresent
Ludwig-Maximilians-Universität München Masters (Diplom) Physics
Ludwig-Maximilians Universität München / University of Munich Masters (Diplom) Physics
Cornell University PhD Physics